The trend for more monophasic growth in HER2 non-amplified compared to HER2 amplified tumors was reflected in a lower median number of morphologically different tumor components per tumor (1 vs. 2 in the HER2 amplified group) and the absence of tumors with more than two components. Here, ERBB2 is linked to neoplasm.